Vetria Peptide Sciences

Healing is a signal.

Animal health focus

Peptide science for animal health.

Vetria Peptide Sciences evaluates peptide-based therapeutic opportunities for dogs, cats and performance horses.

Peptides are short chains of amino acids. They are studied widely for the roles they play in biological signalling, including repair, inflammation and tissue maintenance.

Vetria evaluates where that science fits veterinary practice. We work one species and one defined need at a time. All work is at an early evaluation stage.

Dog receiving a clinical veterinary examination
Canis lupus familiaris

Dogs

Our canine work looks at mobility, post-operative recovery, inflammation, wound healing and gastrointestinal protection, where owners and veterinarians already track outcomes closely.

Cat during a clinical veterinary examination
Felis catus

Cats

Feline evaluation centers on chronic inflammatory and gastrointestinal needs, and takes the distinct metabolism, dosing and handling realities of cats as a starting condition rather than an afterthought.

Performance horse moving through a working stable environment
Equus caballus

Performance horses

Equine evaluation concentrates on tendon, ligament and soft tissue injury, plus wound care, within the training, competition and welfare realities of working horses.

Proposed areas of focus

Seven needs, grouped into three areas.

Each area pairs a defined veterinary need with the species it applies to. Selection is driven by whether the need is measurable in practice and whether peptide signalling is a sensible place to look.

Showing 7 of 7 areas

01

Mobility and recovery

Orthopedic and soft tissue needs where recovery time and function are already measured in practice.

  • Dogs

    Post-operative orthopedic recovery

  • Performance horses

    Tendon and ligament injury

  • Performance horses

    Soft tissue repair

  • Dogs

    Inflammation associated with osteoarthritis

02

Inflammation and gastrointestinal health

Chronic conditions where current management is long running and tolerability matters as much as effect.

  • Cats

    Chronic inflammatory disease

  • Cats and dogs

    Gastrointestinal mucosal protection

03

Skin and wound care

Surface repair needs common to companion and working animals.

  • Dogs and performance horses

    Topical wound healing

Areas under evaluation. Program selection and development plans remain subject to scientific review.

Development approach

How we decide what to pursue.

Peptide signalling is well studied in human and animal biology. The open question in veterinary medicine is which needs it fits, in which species, and on what evidence. That question sets our order of work.

01

Species first

Candidate selection, formulation and delivery start from the physiology, tolerability and daily care realities of the species in question. A molecule that suits a horse rarely suits a cat unchanged.

02

Evidence we can point to

Every program needs a defined veterinary need, endpoints a clinician already measures and controlled evidence appropriate to the proposed use. We hold decisions until that evidence exists.

03

Built with partners

Vetria intends to work with animal health companies, veterinary practices and research groups as programs are selected and development plans take shape.

Leadership and advisors

Experience across science, medicine and finance.

Vetria brings together drug development, veterinary medicine, regulatory affairs, elite sports medicine and public company finance. Nine people, each with a defined role in how programs are chosen and evaluated.

Read full biographies